Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

Published:2015-06-17 Issue:6 Volume:10 Page:e0123683
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Agelaki Sofia,Kalykaki Antonia,Markomanolaki Harris,Papadaki Maria A.,Kallergi Galatea,Hatzidaki Dora,Kalbakis Kostas,Mavroudis Dimitrios,Georgoulias Vassilis

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Systemic spread is an early step in breast cancer;Y Husemann;Cancer Cell,2008

2. Circulating tumor cells in breast cancer;M Ignatiadis;Curr Opin Obstet Gynecol,2008

3. A pooled analysis of bone marrow micrometastasis in breast cancer;S Braun;N Engl J Med,2005

4. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance;A Stathopoulou;J Clin Oncol,2002

5. Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients;N Xenidis;J Clin Oncol,2006

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Fas/Fas Ligand Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Patients with Metastatic Breast Cancer;Cancers;2024-08-23

2. Biobanks in chronic disease management: A comprehensive review of strategies, challenges, and future directions;Heliyon;2024-06

3. Circulating Tumor Cells: How Far Have We Come with Mining These Seeds of Metastasis?;Cancers;2024-02-17

4. Clinical applications of circulating tumor cells in patients with solid tumors;Clinical & Experimental Metastasis;2024-01-28

5. Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells—The DETECT III Clinical Trial;Clinical Chemistry;2024-01